FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
FK-960, 208186-69-0 ;133920-70-4 (free), FK-960 Intermediate 5632-47-3, stock 500.6g, white powder, assay by HPLC 99%, HNMR, LCMS we supply. |
FK-960, 208186-69-0 ; 133920-70-4 (free), FK-960 Intermediate 73742-56-0, stock 852.4g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
FK-960, 208186-69-0 ; 133920-70-4 (free), FK-960 Intermediate 73742-59-3, stock 425.7g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
FK-960, 208186-69-0 ; 133920-70-4 (free), FK-960 Intermediate 403-43-0, stock 832.5g, white powder, assay by HPLC 99.5%, HNMR, LCMS we supply. |
FK-960, 208186-69-0 ; 133920-70-4 (free), FK-960 Intermediate 133920-70-4, stock 732.5g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |